[Polymorphism Lys751Gln of XPD gene and breast cancer risk in women]
Related Experiment Video
Updated: Jul 9, 2026

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
Hanna Romanowicz-Makowska1, Beata Smolarz
1Instytut Centrum Zdrowia Matki Polki w Łodzi, Pracownia Biologii Molekularnej, Zakład Patomorfologii Klinicznej.
Unlabelled:
Polymorphisms in DNA repair genes resulting in variation of DNA repair efficiency may therefore be associated with cancer risk.
Aim Of The Study:
In the present work the distribution of genotypes and frequency of alleles of the Lys751Gln polymorphism of XPD gene in subjects with breast cancer were investigated.
Material And Methods:
Genomic DNA isolated from 92 breast cancer patients and control (n=110) was used to genotype XPD Lys751Gln by means of polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis.
Results:
The distribution of the genotypes of the Lys751Gln polymorphism of XPD in both control and patients did not differ significantly (p > 0.05) from those predicted by the Hardy-Weinberg distribution. There were no significant differences (p > 0.05) in genotype distributions and allele frequencies between subgroups assigned to histological stage.
Conclusions:
The results suggest that the Lys751Gln polymorphism of XPD gene may not be linked with appearance and development of breast cancer.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Pleiotropy
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu